Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Moorehead

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos One|November 10, 2018
Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancerRobert A Jones, Sarah E Franks, Roger A Moorehead
Oncogene|February 14, 2003
Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinomaRoger A Moorehead, Otto H Sanchez, R Mitchell Baldwin, et al.
Oncotarget|December 15, 2015
Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesisS Elizabeth Franks, Ritesh Briah, Robert A Jones, et al.
Experimental Cell Research|April 28, 2018
The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell lineKatrina L Watson, Robert A Jones, Anthony Bruce, et al.
BMC Cancer|February 7, 2015
High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic miceKatrina L Watson, Leanne Stalker, Robert A Jones, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancerNicole E Campbell, James Greenaway, Jack Henkin, et al.
Plos One|September 27, 2014
IGF-IR mediated mammary tumorigenesis is enhanced during pubertal developmentRobert A Jones, Katrina L Watson, Craig I Campbell, et al.
Molecular Cancer Research : MCR|May 29, 2008
Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptorRobert A Jones, Craig I Campbell, James J Petrik, et al.
Cancer Cell International|August 18, 2011
Murine mammary tumor cells with a claudin-low genotypeCraig I Campbell, Devan E Thompson, Megan D Siwicky, et al.
International Journal of Molecular Sciences|September 28, 2023
Loss of <i>MXRA8</i> Delays Mammary Tumor Development and Impairs MetastasisKaitlyn E Simpson, Christina A Staikos, Katrina L Watson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos One|November 10, 2018
Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancerRobert A Jones, Sarah E Franks, Roger A Moorehead
Oncogene|February 14, 2003
Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinomaRoger A Moorehead, Otto H Sanchez, R Mitchell Baldwin, et al.
Oncotarget|December 15, 2015
Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesisS Elizabeth Franks, Ritesh Briah, Robert A Jones, et al.
Experimental Cell Research|April 28, 2018
The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell lineKatrina L Watson, Robert A Jones, Anthony Bruce, et al.
BMC Cancer|February 7, 2015
High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic miceKatrina L Watson, Leanne Stalker, Robert A Jones, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancerNicole E Campbell, James Greenaway, Jack Henkin, et al.
Plos One|September 27, 2014
IGF-IR mediated mammary tumorigenesis is enhanced during pubertal developmentRobert A Jones, Katrina L Watson, Craig I Campbell, et al.
Molecular Cancer Research : MCR|May 29, 2008
Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptorRobert A Jones, Craig I Campbell, James J Petrik, et al.
Cancer Cell International|August 18, 2011
Murine mammary tumor cells with a claudin-low genotypeCraig I Campbell, Devan E Thompson, Megan D Siwicky, et al.
International Journal of Molecular Sciences|September 28, 2023
Loss of <i>MXRA8</i> Delays Mammary Tumor Development and Impairs MetastasisKaitlyn E Simpson, Christina A Staikos, Katrina L Watson, et al.
Pageof 4